HEOR Services — Economic Modeling, HTA Submissions & Value Communication

  • Home
  • Service
  • HEOR Services — Economic Modeling, HTA Submissions & Value Communication

HEOR Services — Economic Modeling, HTA Submissions & Value Communication

Building a credible evidence base is critical to demonstrating the economic and clinical value of new therapies, devices, and treatment approaches. Evysaif offers end-to-end Health Economics & Outcomes Research services, delivered by a multidisciplinary team with deep expertise in both global and regional evidence requirements.

We partner with pharmaceutical, biotech, and medical device companies across the product lifecycle, from early development through market access and payer negotiations. Our HEOR specialists support healthcare decision-makers in understanding treatment costs, comparative effectiveness, and real-world outcomes using scientifically rigorous and commercially relevant methods.

From economic model development and systematic literature reviews to HTA dossiers and value communication, we combine analytical precision with strategic insight, giving you the evidence you need to achieve payer approval and drive better health outcomes.

Our HEOR services span the full product lifecycle:

Evidence Review & Synthesis
Systematic literature reviews (SLRs), meta-analyses, and network meta-analyses (NMAs) built to meet global HTA evidentiary standards delivering a robust, credible foundation for reimbursement and market access decisions.

Health Economic Modeling
From Markov cohort models and decision tree analyses to budget impact models (BIMs) and cost-effectiveness analyses (CEAs), our economic models are designed for HTA submissions, ICER evaluations, and payer negotiations across global markets.

HTA Trial Analyses
Indirect treatment comparisons (ITCs), survival extrapolation, subgroup analyses, and trial data interpretation strengthening your reimbursement dossiers and improving HTA review outcomes.

Value & Market Access
Early value frameworks, QALY-based assessments, patient-reported outcomes (PRO) strategy, and HTA submission support accelerating payer approval from development through product launch.

Value Communication
Global value dossiers (GVDs), AMCP dossiers, HTA briefing books, health economic publications, white papers, and infographics translating complex HEOR evidence into compelling stakeholder communication.

1
We map your evidence landscape, identify gaps, and define HTA and payer requirements across target markets.
2
We build Markov models, decision trees, cost-effectiveness, and budget impact analyses for global HTA submissions.
3
We deliver SLRs, NMAs, real-world data analyses, and PRO strategies — packaged for reimbursement and payer dossiers.
4
We craft global value dossiers, HTA briefing books, and HEOR publications that drive market access and payer approval.

Evysaif combines economic modeling expertise, scientific rigor, and strategic value communication to deliver the evidence payers and HTAs need.

Our Services
Subscribe to Our Newsletter